07/11/2023 8:28 PM | Chacko Jacob (Reporting) ORIC Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/07/2023 3:15 PM | Nextech Crossover I GP S.a r.l. (Filed by) ORIC Pharmaceuticals (Subject)
| Form SC 13G | |
07/05/2023 2:27 PM | ORIC Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
06/28/2023 6:18 PM | Chacko Jacob (Reporting) ORIC Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 5:05 AM | ORIC Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/26/2023 5:25 PM | Chacko Jacob (Reporting) ORIC Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2023 3:21 PM | ORIC Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
|
03/16/2023 3:21 PM | ORIC Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/16/2023 3:11 PM | ORIC Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/17/2023 3:22 PM | Chacko Jacob (Reporting) ORIC Pharmaceuticals (Issuer)
| Form 4/A | |
02/13/2023 9:15 AM | ALKEON CAPITAL MANAGEMENT LLC (Filed by) ORIC Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/10/2023 12:56 PM | EcoR1 Capital, LLC (Filed by) ORIC Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2023 11:01 AM | ORIC Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/06/2023 8:50 AM | ORIC Pharmaceuticals (Subject) VICTORY CAPITAL MANAGEMENT INC (Filed by)
| Form SC 13G/A | |
02/02/2023 3:09 PM | Chacko Jacob (Reporting) ORIC Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2023 3:11 PM | ORIC Pharmaceuticals (Issuer) Piscitelli Dominic (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2023 3:13 PM | Multani Pratik S (Reporting) ORIC Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2023 7:12 AM | ORIC Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/29/2022 3:41 PM | ORIC Pharmaceuticals (Subject) PFIZER INC (Filed by)
| Form SC 13G | |
12/29/2022 3:30 PM | ORIC Pharmaceuticals (Issuer) PFIZER INC (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/27/2022 3:36 PM | ORBIMED ADVISORS LLC (Filed by) ORIC Pharmaceuticals (Subject)
| Form SC 13D/A | |
12/21/2022 4:23 PM | ORIC Pharmaceuticals (Filer)
| Form 424B5 | |
12/21/2022 4:25 PM | ORIC Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/16/2022 7:51 PM | Multani Pratik S (Reporting) ORIC Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2022 7:47 PM | Chacko Jacob (Reporting) ORIC Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2022 7:49 PM | ORIC Pharmaceuticals (Issuer) Piscitelli Dominic (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2022 3:21 PM | ORIC Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2022 3:10 PM | ORIC Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |